ABSTRACT BACKGROUND Pulse pressure (PP) provides valuable prognostic information in specific populations, but few studies
. Thus, understanding whether peripheral PP is clinically useful warrants further study. Finally, although a significant proportion, though certainly not all (12, 13) , of the PP data have been generated from hypertensive clinical trials with restricted patient populations, less is known about its relationship to a broad array of subjects in an outpatient setting. We therefore sought to examine the relationship between PP and adverse cardiovascular events using data from the REACH (Reduction of Atherothrombosis for Continued Health) registry. 
CLINICAL CHARACTERISTICS AND OUTCOME VARIABLES.
Baseline height, weight, and seated systolic blood pressure (SBP) and diastolic blood pressure (DBP) were obtained. Blood pressure was measured using a brachial mercury sphygmomanometer. PP was defined as the difference between the SBP and DBP. A quality control check with the number of blood pressure readings ending in zero was performed (18) and showed that 58% of SBP readings and 60% of DBP readings ended in zero (20% expected). Body mass index (BMI) was defined as weight in kilograms divided by the square of height in meters. Medical history and medications were established using All primary analyses were repeated using SBP and DBP as the predictor variables instead of PP. A 2-sided p value #0.05 was considered to indicate statistical significance. Analysis was performed using SAS version 9.3 (SAS Institute Inc., Cary, North Carolina).
RESULTS

CHARACTERISTICS
OF STUDY PARTICIPANTS.
Descriptive characteristics of the REACH study sample are displayed in Unadjusted relationship between pulse pressure quartiles and outcomes (p < 0.01 for trend of all outcomes). Mean pulse pressure (millimeters of mercury) is labeled on the x-axis for each pulse pressure quartile.
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Pulse Pressure and Cardiovascular Outcomes Pulse pressure as a continuous variable is nonlinearly associated with cardiovascular death, fatal and nonfatal stroke, and the combined outcome of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, or cardiovascular hospitalization (p < 0.05 for nonlinearity).
However, pulse pressure is linearly associated with nonfatal myocardial infarction, fatal and nonfatal myocardial infarction, nonfatal stroke, and cardiovascular hospitalization (p ¼ 0.95, p ¼ 0.70, p ¼ 0.14, and p ¼ 0.84 for nonlinearity, respectively). CI ¼ confidence interval.
Pulse Pressure and Cardiovascular Outcomes When stratifying by SBP levels using 140 mm Hg as the cutoff, the relationships between PP and nonfatal MI as well as the combined outcome were significant in hypertensive patients (p # 0.05 for both Unadjusted hazard ratios with 95% confidence intervals (CIs) are depicted per 10 mm Hg increase in pulse pressure for all adverse cardiovascular (CV) outcomes. The combined outcome comprises CV death, myocardial infarction (MI), stroke, or CV hospitalization.
Furthermore, given the large population and significant number of events, we were able to perform multiple sensitivity analyses to define more precisely the relationship between PP and adverse events in several subgroups. Of note, strong relationships were observed in participants without established atherothrombotic disease, suggesting that despite being lower risk, PP still has strong prognostic value. In participants older than 60 years of age, PP was associated with nonfatal MI and cardiovascular hospitalization. As shown previously, PP is particularly useful in older patients, because SBP and DBP tend to diverge after age 55 (23) . Therefore, the resultant PP widening becomes a more accurate assessment of vascular bed compliance and cardiovascular risk.
The degree of SBP, we found, was also important.
In hypertensive patients, there were significant increases in nonfatal MI and the combined outcome.
However, in nonhypertensive subjects, this relationship with cardiovascular outcomes was mixed.
Increasing PP was associated with higher risk for nonfatal MI and cardiovascular hospitalization; The large sample size of the present study provided enough power to detect a relationship. The relative risks for adverse events calculated here are comparable with those observed in previous studies (20, 28) .
We also examined the relationship between both SBP and DBP and adverse cardiovascular events. PP and SBP followed similar trends, as changes in PP quartiles largely reflect changes in SBP. In addition, there were J-shaped relationships between DBP and a few outcomes, including the combined outcome, which is consistent with a large, previous study in patients with atherothrombosis, in whom low blood pressure may not be ideal (19, 29) . Low diastolic pressure may be poorly tolerated because this may reflect reduced coronary filling, which predominantly occurs during diastole. Conversely, low DBP may reflect "reverse causality," wherein low pressure is a symptom of the disease, not a cause, and therefore may
Selvaraj et al. However, obtaining these data requires special devices not amenable to routine clinical practice; in addition, a recent meta-analysis showed that central PP does not offer a significant increase in predictive ability over peripheral PP (28) .
Second, heart rate was not collected and therefore could not be adjusted for on multivariate analysis.
Third, REACH studied high-risk subjects with clinical atherothrombotic disease or multiple risk factors for atherothrombosis. Therefore, our results may not be generalizable to healthier cohorts. However, we performed subgroup analysis in subjects without established atherothrombosis, and many adverse relationships were still observed.
Fourth, REACH did not identify subjects with severe aortic stenosis, which could explain the relationship between low PP and increased cardiovascular mortality even after excluding patients with heart failure.
Fifth, the REACH registry does not provide ambulatory blood pressure measurements, which have been shown to improve cardiovascular risk stratification (35) .
Sixth, our study demonstrated digit preference bias, reflected by the higher than expected number of blood pressure readings ending in zero, which has been observed in numerous previous studies (36-38).
It is not clear if this affected our results, but it does underscore the need for better training in the measurement of blood pressure in clinical practice.
CONCLUSIONS
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